Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study
- PMID: 18598886
- PMCID: PMC4385517
- DOI: 10.1016/j.jacc.2008.01.074
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study
Abstract
Objectives: We characterized a large cohort of children who had a Fontan procedure, with measures of functional health status, ventricular size and function, exercise capacity, heart rhythm, and brain natriuretic peptide (BNP).
Background: The characteristics of contemporary Fontan survivors are not well described.
Methods: We enrolled 546 children (age 6 to 18 years, mean 11.9 years) and compared them within pre-specified anatomic and procedure subgroups. History and outcome measures were obtained within a 3-month period.
Results: Predominant ventricular morphology was 49% left ventricular (LV), 34% right ventricular (RV), and 19% mixed. Ejection fraction (EF) was normal for 73% of subjects; diastolic function grade was normal for 28%. Child Health Questionnaire mean summary scores were lower than for control subjects; however, over 80% of subjects were in the normal range. Brain natriuretic peptide concentration ranged from <4 to 652 pg/ml (median 13 pg/ml). Mean percent predicted peak O2 consumption was 65% and decreased with age. Ejection fraction and EF Z score were lowest, and semilunar and atrioventricular (AV) valve regurgitation were more prevalent in the RV subgroup. Older age at Fontan was associated with more severe AV valve regurgitation. Most outcomes were not associated with a superior cavopulmonary connection before Fontan.
Conclusions: Measures of ventricular systolic function and functional health status, although lower on average in the cohort compared with control subjects, were in the majority of subjects within 2 standard deviations of the mean for control subjects. Right ventricular morphology was associated with poorer ventricular and valvular function. Effective strategies to preserve ventricular and valvular function, particularly for patients with RV morphology, are needed.
Figures


Comment in
-
The Fontan procedure our Odyssey continues.J Am Coll Cardiol. 2008 Jul 8;52(2):114-6. doi: 10.1016/j.jacc.2008.03.042. J Am Coll Cardiol. 2008. PMID: 18598889 No abstract available.
References
-
- Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation. 2007;115:800–812. - PubMed
-
- Landgraf JM, Abetz L, Ware JE. The Child Health Questionnaire (CHQ) User's Manual. Second Printing. Boston, MA: HealthAct; 1999.
-
- Perwien AR, Kratochvil CJ, Faries DE, Vaughan BS, Spencer T, Brown RT. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol. 2006;16:713–724. - PubMed
-
- Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol. 2005;99:445–457. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL68288/HL/NHLBI NIH HHS/United States
- U01 HL068269/HL/NHLBI NIH HHS/United States
- U01 HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068290/HL/NHLBI NIH HHS/United States
- U01 HL068288/HL/NHLBI NIH HHS/United States
- U10 HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068281/HL/NHLBI NIH HHS/United States
- HL68270/HL/NHLBI NIH HHS/United States
- HL68279/HL/NHLBI NIH HHS/United States
- HL68285/HL/NHLBI NIH HHS/United States
- U10 HL109778/HL/NHLBI NIH HHS/United States
- HL68292/HL/NHLBI NIH HHS/United States
- HL68281/HL/NHLBI NIH HHS/United States
- U01 HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068292/HL/NHLBI NIH HHS/United States
- U01 HL68269/HL/NHLBI NIH HHS/United States
- U01 HL068285/HL/NHLBI NIH HHS/United States
- HL68290/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical